Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors.

Journal of medicinal chemistry·2026
Same author

Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma.

Cancer research·2025
Same author

A Dehydration-Diffusion Competition Framework Predicts Interfacial Film Risk in High-Concentration Biologics Fill-Finish.

Molecular pharmaceutics·2025
Same author

Development of Flow-NMR Spectroscopy for Real-Time Monitoring and Kinetics Studies of Biomolecules: Case Study of Liraglutide Oligomerization.

Analytical chemistry·2025
Same author

Rapid Characterization of Structural and Behavioral Changes of Therapeutic Proteins by Relaxation and Diffusion <sup>1</sup>H-SOFAST NMR Experiments.

Analytical chemistry·2024
Same author

Biostructural, biochemical and biophysical studies of mutant IDH1.

Nature communications·2024

Related Experiment Video

Updated: Oct 5, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

419

NMR Data-Driven Docking of HDM2-Inhibitor Complexes.

Xavier Fradera1,2, Michael H Reutershan3,4, Michelle R Machacek3

  • 1Computational and Structural Chemistry, Merck & Co., Inc, Boston, MA and Kenilworth, NJ, USA.

Chembiochem : a European Journal of Chemical Biology
|February 1, 2022
PubMed
Summary

We developed an automated workflow using Nuclear Magnetic Resonance (NMR) data to model protein-ligand complexes. This method accurately predicts binding poses for drug discovery, as demonstrated with HDM2 protein inhibitors.

Keywords:
HDM2NMR spectroscopydrug designmolecular dockingstructural biology

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.5K

Related Experiment Videos

Last Updated: Oct 5, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

419
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.5K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Computational Chemistry

Background:

  • Accurate modeling of protein-ligand complexes is crucial for drug discovery.
  • Protein flexibility and experimental data integration pose challenges in molecular modeling.

Purpose of the Study:

  • To present an automated workflow for generating protein-ligand complex models using Nuclear Magnetic Resonance (NMR) data.
  • To improve the accuracy of docking pose prediction by incorporating experimental Nuclear Overhauser Effect (NOE) constraints.

Main Methods:

  • Generating intermolecular distance constraints from experimental NOE NMR data.
  • Docking ligands to an ensemble of receptor structures to account for protein flexibility.
  • Filtering and scoring docking poses based on NOE constraint consistency.

Main Results:

  • Successfully generated models of protein-ligand complexes using the automated workflow.
  • Demonstrated the workflow's utility in a lead optimization project involving HDM2 protein and synthetic inhibitors.
  • Validated the method's ability to predict binding poses consistent with experimental NOE data.

Conclusions:

  • The automated NMR-guided docking workflow provides a robust method for modeling protein-ligand interactions.
  • This approach enhances the accuracy of molecular modeling by integrating experimental NOE data and accounting for protein flexibility.
  • The workflow is effective for structure-based drug design, particularly for protein-protein interaction inhibitors.